Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-12-032674
Filing Date
2012-05-25
Accepted
2012-05-25 12:51:58
Documents
2
Period of Report
2012-03-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd346834.html 3  
1 FORM 3 rrd346834.xml 3 2796
2 EXHIBIT 24 rrd311187_351310.htm EX-24. 3989
  Complete submission text file 0001181431-12-032674.txt   8243
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GALECTIN THERAPEUTICS INC 7 WELLS AVENUE NEWTON MA 02459
Business Address
MCGAULEY THOMAS (Reporting) CIK: 0001550701 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31791 | Film No.: 12870244